Acuracet® Tablets

Acuracet® (oxycodone HCl/APAP) Tablets

Acuracet® is an immediate release opioid analgesic tablet with a proposed indication for relief of moderate-to-severe pain and is designed to introduce limits and impediments to potential abuse via nasal snorting of crushed tablets and intravenous injection of dissolved tablets.  Acuracet® contains two active analgesics: the opioid oxycodone HCl and acetaminophen (APAP).

Status

King Pharmaceuticals Research and Development, Inc. (King) our development and commercialization partner licensed Acuracet® Tablets in December 2007.

Development Program

Ongoing development, manufacture, and commercialization of Acuracet® Tablets is the responsibility of King.